Phase 4 Study Evaluating Efficacy and Safety of Rozanolixizumab in Adult Chinese Participants With Generalized Myasthenia Gravis
Clinical trial NCT07246564 · RECRUITING
Trial details
- NCT number
- NCT07246564
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-10-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.